Clinical Trial Update: Gemcitabine-Cisplatin-90Y TARE for Unresectable Intrahepatic Cholangiocarcinoma [NA]

View source ↗

Summary

A clinical trial evaluating gemcitabine, cisplatin, and Yttrium-90 radioembolization for unresectable intrahepatic cholangiocarcinoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrahepatic Cholangiocarcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)
• Yttrium-90 (yttrium-90)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Intrahepatic Cholangiocarcinoma | NA | Status: TERMINATED